Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial

Kate Brain, Ben Carter, Kate J Lifford, Olivia Burke, Anand Devaraj, David R Baldwin, Stephen Duffy, John K Field, Kate Brain, Ben Carter, Kate J Lifford, Olivia Burke, Anand Devaraj, David R Baldwin, Stephen Duffy, John K Field

Abstract

Background: Smoking cessation was examined among high-risk participants in the UK Lung Cancer Screening (UKLS) Pilot Trial of low-dose CT screening.

Methods: High-risk individuals aged 50-75 years who completed baseline questionnaires were randomised to CT screening (intervention) or usual care (no screening control). Smoking habit was determined at baseline using self-report. Smokers were asked whether they had quit smoking since joining UKLS at T1 (2 weeks after baseline scan results or control assignment) and T2 (up to 2 years after recruitment). Intention-to-treat (ITT) regression analyses were undertaken, adjusting for baseline lung cancer distress, trial site and sociodemographic variables.

Results: Of a total 4055 individuals randomised to CT screening or control, 1546 were baseline smokers (759 intervention, 787 control). Smoking cessation rates were 8% (control n=36/479) versus 14% (intervention n=75/527) at T1 and 21% (control n=79/377) versus 24% (intervention n=115/488) at T2. ITT analyses indicated that the odds of quitting among screened participants were significantly higher at T1 (adjusted OR (aOR) 2.38, 95% CI 1.56 to 3.64, p<0.001) and T2 (aOR 1.60, 95% CI 1.17 to 2.18, p=0.003) compared with control. Intervention participants who needed additional clinical investigation were more likely to quit in the longer term compared with the control group (aOR 2.29, 95% CI 1.62 to 3.22, p=0.007) and those receiving a negative result (aOR 2.43, 95% CI 1.54 to 3.84, p<0.001).

Conclusions: CT lung cancer screening for high-risk participants presents a teachable moment for smoking cessation, especially among those who receive a positive scan result. Further behavioural research is needed to evaluate optimal strategies for integrating smoking cessation intervention with stratified lung cancer screening.

Trial registration number: Results, ISRCTN 78513845.

Keywords: Lung Cancer; Smoking cessation.

Conflict of interest statement

Competing interests: None declared.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Figures

Figure 1
Figure 1
Trial CONSORT diagram. UKLS, UK Lung Cancer Screening.

References

    1. World Lung Foundation/American Cancer Society. The tobacco atlas. (accessed 18 Mar 2016).
    1. Cancer Research UK. Lung cancer risk factors. (accessed 18 Mar 2016).
    1. ASH. Smoking statistics. (accessed 18 Mar 2016).
    1. ASH. Smoking statistics: who smokes and how much. (accessed 18 Mar 2016).
    1. Office for National Statistics. Do smoking rates vary between more and less advantaged areas? (accessed 18 Mar 2016).
    1. van Klaveren RJ, Oudkerk M, Prokop M, et al. . Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:2221–9. 10.1056/NEJMoa0906085
    1. Pedersen J, Ashraf H, Dirksen A, et al. . The Danish randomized lung cancer CT screening trial—overall design and results of the prevalence round. J Thorac Oncol 2009;5:608–14. 10.1097/JTO.0b013e3181a0d98f
    1. Aberle DR, Adams AM, Berg CD, et al. . Reduced lung cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395–409. 10.1056/NEJMoa1102873
    1. Field JK, Duffy SW, Baldwin DR, et al. . United Kingdom Lung Cancer RCT Pilot Screening Trial (UKLS): baseline findings from the screening arm provide evidence for a cost effective exemplar for implementation of lung cancer screening. Thorax 2016;71:161–70. 10.1136/thoraxjnl-2015-207140
    1. Ostroff JS, Buckshee N, Mancuso CA, et al. . Smoking cessation following CT screening for early detection of lung cancer. Prev Med 2001;33:613–21. 10.1006/pmed.2001.0935
    1. Ashraf H, Tønnesen P, Holst Pedersen J, et al. . Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST). Thorax 2009;64:388–92. 10.1136/thx.2008.102475
    1. van der Aalst CM, van den Bergh KA, Willemsen MC, et al. . Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial. Thorax 2010;65:600–5. 10.1136/thx.2009.133751
    1. van der Aalst CM, van Klaveren RJ, van den Bergh KA, et al. . The impact of a lung cancer computed tomography screening result on smoking abstinence. Eur Respir J 2011;37:1466–73. 10.1183/09031936.00035410
    1. Tammemägi MC, Berg CD, Riley TL, et al. . Impact of lung cancer screening results on smoking cessation. J Natl Cancer Instit 2014;106(6):dju084 10.1093/jnci/dju084
    1. Townsend CO, Clark MM, Jett JR, et al. . Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening. Cancer 2005;103:2154–62. 10.1002/cncr.21045
    1. Brain K, Lifford KJ, Carter B, et al. . Long-term psychosocial outcomes of low dose computed tomography screening: results of the UK Lung Cancer Screening (UKLS) randomised controlled trial. Thorax 2016;71:996–1005. 10.1136/thoraxjnl-2016-208283
    1. McRonald F, Yadegarfar G, Baldwin D, et al. . The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening. Cancer Prev Res 2014;7:362–71. 10.1158/1940-6207.CAPR-13-0206
    1. Ali N, Lifford KJ, Carter B, et al. . Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed-methods analysis of the United Kingdom Lung Cancer Screening (UKLS) trial. BMJ Open 2015;5:e008254 10.1136/bmjopen-2015-008254
    1. Lerman C, Daly M, Sands C. Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 1993;85:1074–80. 10.1093/jnci/85.13.1074
    1. Watson M, Lloyd S, Davidson J, et al. . The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. Brit J Cancer 1999;79:868–74. 10.1038/sj.bjc.6690139
    1. Brain K, Parsons E, Bennett P, et al. . The evolution of worry after breast cancer risk assessment: 6-year follow-up of the TRACE study cohort. Psychooncol 2011;20:984–91. 10.1002/pon.1807
    1. West R, Hajek P, Stead L, et al. . Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005;100:299–303. 10.1111/j.1360-0443.2004.00995.x
    1. Seaman SR, White IR. Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res 2013;22:278–95. 10.1177/0962280210395740
    1. Field JK, Duffy SW, Baldwin DR, et al. . The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Health Technol Assess 2016;20:1–146. 10.3310/hta20400
    1. DiClemente CC, Prochaska JO, Fairhurst SK, et al. . The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Cons Clin Psychol 1991;59:295–304. 10.1037/0022-006X.59.2.295
    1. Jonnalagadda S, Bergamo C, Lin JJ, et al. . Beliefs and attitudes about lung cancer screening among smokers. Lung Cancer 2012;77:526–31. 10.1016/j.lungcan.2012.05.095
    1. Patel D, Akporobaro A, Chinyanganya N, et al. . Attitudes to participation in a lung cancer screening trial: a qualitative study. Thorax 2013;67:418–25. 10.1136/thoraxjnl-2011-200055
    1. Quaife SL, McEwen A, Janes SM, et al. . Smoking is associated with pessimistic and avoidant beliefs about cancer: results from the International Cancer Benchmarking Partnership. Br J Cancer 2015;112:1799–804. 10.1038/bjc.2015.148
    1. Silvestri GA, Nietert PJ, Zoller J, et al. . Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts. Thorax 2007;62:126–30. 10.1136/thx.2005.056036
    1. van den Bergh KAM, Essink-Bot ML, van Klaveren RJ, et al. . Informed participation in a randomised controlled trial of computed tomography screening for lung cancer. Eur Respir J 2009;34:711–20. 10.1183/09031936.00098908
    1. Quaife SL, Marlow LA, McEwen A, et al. . Attitudes towards lung cancer screening in socioeconomically deprived and heavy smoking communities: informing screening communication. Health Expect. Published Online First: 11 Jul 2016. doi:10.1111/hex.12481. 10.1111/hex.12481
    1. Hiscock R, Murray S, Brose LS, et al. . Behavioural therapy for smoking cessation: the effectiveness of different intervention types for disadvantaged and affluent smokers. Addict Behav 2013;38:2787–96. 10.1016/j.addbeh.2013.07.010
    1. Free C, Knight R, Robertson S, et al. . Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial. Lancet 2011;378:49–55. 10.1016/S0140-6736(11)60701-0
    1. Hajek P, Stead LF, West R, et al. . Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev 2013;8:CD003999.
    1. Piñeiro B, Simmons VN, Palmer AM, et al. . Smoking cessation interventions within the context of Low-Dose Computed Tomography lung cancer screening: a systematic review. Lung Cancer 2016;98:91–8. 10.1016/j.lungcan.2016.05.028

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe